BIO-RAD LABORATORIES-A (BIO) Stock Earnings Estimates
USA • New York Stock Exchange • NYSE:BIO • US0905722072
293.7 USD
-1.21 (-0.41%)
At close: Jan 30, 2026
293.7 USD
0 (0%)
After Hours: 1/30/2026, 8:04:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.802B -4.12% | 2.671B -4.67% | 2.567B -3.92% | 2.605B 1.50% | 2.663B 2.23% | 2.76B 3.64% | 2.711B -1.78% | 2.772B 2.25% | |
| EBITDA YoY % growth | N/A -13.40% | N/A -19.14% | N/A -8.95% | 455.39M -3.71% | 478.14M 5.00% | 513.67M 7.43% | 445.93M -13.19% | 477.58M 7.10% | |
| EBIT YoY % growth | 486.8M -13.79% | 365.696M -24.88% | 298.5M -18.37% | 312.13M 4.57% | 334.19M 7.07% | 367.64M 10.01% | 531.26M 44.51% | N/A | |
| Operating Margin | 17.37% | 13.69% | 11.63% | 11.98% | 12.55% | 13.32% | 19.60% | N/A | |
| EPS YoY % growth | 14.23 -9.19% | 11.77 -17.29% | 10.31 -12.40% | 10.05 -2.48% | 10.25 1.95% | 11.38 10.97% | 8.95 -21.33% | 9.01 0.68% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.74 -5.69% | 2.53 -0.40% | 2.72 4.28% | 2.59 14.57% | 2.92 6.66% | 3.06 20.77% | 3.01 10.77% | 2.94 13.70% | 3.24 11.14% |
| Revenue Q2Q % growth | 700.89M 5.00% | 606.45M 3.60% | 672.32M 3.18% | 678.27M 3.87% | 723.64M 3.25% | 641.59M 5.79% | 704.48M 4.78% | 696.02M 2.62% | 759.27M 4.92% |
| EBITDA Q2Q % growth | 128.57M -3.99% | 106.45M 26.80% | 129.3M 36.31% | 124.91M 22.16% | 135.71M 5.55% | 124.51M 16.97% | 142.93M 10.54% | 134.97M 8.05% | 147.06M 8.36% |
| EBIT Q2Q % growth | 91.359M 56.62% | 69.626M 22.37% | 92.298M 16.10% | 86.737M 27.93% | 99.694M 9.12% | 85.921M 23.40% | 104.37M 13.08% | 96.824M 11.63% | 108.71M 9.04% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 2.26 12.44% | 1.95 | 0.31 | 15.74% |
| Q2 2025 Q2Q % growth | 2.61 -16.08% | 1.75 | 0.86 | 49.07% |
| Q1 2025 Q2Q % growth | 2.54 10.92% | 1.83 | 0.71 | 38.97% |
| Q4 2024 Q2Q % growth | 2.90 -6.45% | 2.90 | 0.00 | 0.10% |
| Q3 2024 Q2Q % growth | 2.01 -13.73% | 1.17 | 0.84 | 72.05% |
| Q2 2024 Q2Q % growth | 3.11 3.67% | 2.03 | 1.08 | 52.84% |
| Q1 2024 Q2Q % growth | 2.29 -31.44% | 2.17 | 0.12 | 5.67% |
| Q4 2023 Q2Q % growth | 3.10 -6.34% | 2.85 | 0.25 | 8.96% |
| Q3 2023 Q2Q % growth | 2.33 -10.38% | 2.81 | -0.48 | -17.09% |
| Q2 2023 Q2Q % growth | 3.00 -11.24% | 2.71 | 0.29 | 10.88% |
| Q1 2023 Q2Q % growth | 3.34 -32.39% | 3.58 | -0.24 | -6.64% |
| Q4 2022 Q2Q % growth | 3.31 3.12% | 3.48 | -0.17 | -4.96% |
| Q3 2022 Q2Q % growth | 2.60 -29.92% | 2.81 | -0.21 | -7.47% |
| Q2 2022 Q2Q % growth | 3.38 -4.52% | 2.83 | 0.55 | 19.58% |
| Q1 2022 Q2Q % growth | 4.94 -5.18% | 3.44 | 1.50 | 43.76% |
| Q4 2021 Q2Q % growth | 3.21 -19.95% | 2.88 | 0.33 | 11.49% |
| Q3 2021 Q2Q % growth | 3.71 23.67% | 2.46 | 1.25 | 50.71% |
| Q2 2021 Q2Q % growth | 3.54 119.88% | 2.69 | 0.85 | 31.54% |
| Q1 2021 Q2Q % growth | 5.21 172.77% | 3.03 | 2.18 | 72.12% |
| Q4 2020 Q2Q % growth | 4.01 | 3.33 | 0.68 | 20.49% |
| Q3 2020 Q2Q % growth | 3.00 | 1.82 | 1.18 | 64.86% |
| Q2 2020 Q2Q % growth | 1.61 | 1.24 | 0.37 | 30.31% |
| Q1 2020 Q2Q % growth | 1.91 | 1.58 | 0.33 | 20.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 653M 0.50% | 657.81M | -4.81M | -0.73% |
| Q2 2025 Q2Q % growth | 651.6M 2.06% | 621.36M | 30.24M | 4.87% |
| Q1 2025 Q2Q % growth | 585.4M -4.16% | 579M | 6.4M | 1.11% |
| Q4 2024 Q2Q % growth | 667.5M -2.01% | 686.09M | -18.59M | -2.71% |
| Q3 2024 Q2Q % growth | 649.729M 2.79% | 634.46M | 15.269M | 2.41% |
| Q2 2024 Q2Q % growth | 638.476M -6.26% | 652.25M | -13.774M | -2.11% |
| Q1 2024 Q2Q % growth | 610.82M -9.75% | 625.28M | -14.46M | -2.31% |
| Q4 2023 Q2Q % growth | 681.184M -6.73% | 691.94M | -10.756M | -1.55% |
| Q3 2023 Q2Q % growth | 632.1M -7.15% | 696.46M | -64.36M | -9.24% |
| Q2 2023 Q2Q % growth | 681.11M -1.45% | 704.94M | -23.83M | -3.38% |
| Q1 2023 Q2Q % growth | 676.844M -3.32% | 696.73M | -19.886M | -2.85% |
| Q4 2022 Q2Q % growth | 730.3M -0.34% | 749.67M | -19.37M | -2.58% |
| Q3 2022 Q2Q % growth | 680.8M -8.86% | 686.74M | -5.94M | -0.86% |
| Q2 2022 Q2Q % growth | 691.1M -3.46% | 689.45M | 1.65M | 0.24% |
| Q1 2022 Q2Q % growth | 700.1M -3.67% | 681.85M | 18.25M | 2.68% |
| Q4 2021 Q2Q % growth | 732.8M -7.22% | 739.3M | -6.5M | -0.88% |
| Q3 2021 Q2Q % growth | 747M 15.40% | 668.49M | 78.51M | 11.74% |
| Q2 2021 Q2Q % growth | 715.9M 33.34% | 638.1M | 77.8M | 12.19% |
| Q1 2021 Q2Q % growth | 726.8M 27.15% | 667.59M | 59.21M | 8.87% |
| Q4 2020 Q2Q % growth | 789.8M | 693.67M | 96.13M | 13.86% |
| Q3 2020 Q2Q % growth | 647.3M | 576.28M | 71.02M | 12.32% |
| Q2 2020 Q2Q % growth | 536.9M | 522.22M | 14.68M | 2.81% |
| Q1 2020 Q2Q % growth | 571.6M | 552.32M | 19.28M | 3.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.46% | -3.02% | -0.3% | 4.13% |
| Revenue | -0.65% | -1.79% | -0.12% | -0.53% |